Mihael Polymeropoulos

Chief Executive Officer at VANDA PHARMACEUTICALS INC.

Net worth: 10 M $ as of 2026-05-30

66 year

65 connections

Health Technology

Consumer Services

Government

Profile

Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc., founded in 2002.
Titles held at Vanda Pharmaceuticals, Inc. include Chairman, President & Chief Executive Officer since 2021.
Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression..
Former jobs include VP & Head-Pharmacogenetics Department at Novartis AG from 1998 to 2003 and Chief-Gene Mapping Section at National Human Genome Research Institute from 1992 to 1998.
Education includes undergraduate studies at the University of Patras.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VANDA PHARMACEUTICALS INC. 2.64%	2026-04-16	1,588,246 ( 2.64% )	10 M $	2026-05-30

Mihael Polymeropoulos active positions

Companies	Position	Start
VANDA PHARMACEUTICALS INC.	Chief Executive Officer	2003-04-30

All active positions of Mihael Polymeropoulos

Former positions of Mihael Polymeropoulos

Companies	Position	End
NOVARTIS AG	Corporate Officer/Principal	2002-12-31
National Human Genome Research Institute National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research	Corporate Officer/Principal	1997-12-31
Integrated Molecular Analysis of Genome Expression	Founder	-

See the detail of Mihael Polymeropoulos's experience

Training of Mihael Polymeropoulos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mihael Polymeropoulos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Vanda Pharmaceuticals, Inc. Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
University of Patras University of Patras Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Integrated Molecular Analysis of Genome Expression
National Human Genome Research Institute National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research	Government